Ares Capital closed over $530 million across 11 transactions in Q2/16. The following are brief descriptions of the transactions:
- Served as joint lead arranger and joint bookrunner on a $320 million senior secured credit facility to support Harvest Partners’ acquisition of Advanced Dermatology, a dermatology-focused physician practice management company.
- Served as administrative agent and lead arranger on a $150 million second lien term loan to support American Securities’ acquisition of NAPA, a single-specialty anesthesia and perioperative management company in the U.S.
- Served as administrative agent, joint lead arranger and joint bookrunner on a senior secured credit facility to support Genstar Capital’s acquisition of Accruent
- Served as administrative agent, revolver agent, lead arranger and bookrunner for a senior secured credit facility to support a refinancing of Gentle Dental, an Audax Group portfolio company
- Served as administrative agent for an incremental first lien term loan to support Implus Footcare’s acquisition of Spenco, a producer of high quality insoles, foot care products and shoes
- Invested in a second lien term loan to support the merger of MedAssets and Precyse, existing portfolio companies of Pamplona Capital Management
- Served as administrative agent, joint lead arranger and joint bookrunner for a senior secured credit facility to support a dividend recapitalization of Towne Park, a TA Associates’ portfolio company
“Ares Capital’s size and scale has always been a key competitive advantage as we are able to offer full financing solutions to our clients,” said Kipp deVeer, chief executive officer of Ares Capital. “Our market-leading position continues to provide us with investment opportunities, which we believe translate into attractive risk-adjusted returns for our shareholders.”